Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Sustained release triple drug loaded Microbaloons for management of Parkinson’s Disease
Classification of Movement Disorders · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Swallowing assessment in Parkinson’s Disease using Dynamic Magnetic Resonance Imaging (dMRI)
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Symptomatic palatal tremor combined with unilateral limb tremor and parkinsonism
Tremor · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Synaptic dysfuncion in a Drosophila model of PARK14
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Synaptic function in Parkinson’s disease associated with GBA mutations
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Tactile and proprioceptive dysfunction differentiates between cervical dystonia with and without tremor
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Tardive Cervical Dystonia: Treatment with Botulinum: Treatment with Botulinum Toxin Guided by Electromyography
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Task Specific Dystonia and Its Response to Botulinum Neurotoxin Treatment
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Task-specific lower limb dystonia only during walking stairs
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Tau and amyloid-beta inclusions are present in pancreatic beta-cells of patients with synucleinopathies
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 69
- Next Page»